BCRX SG&A Expenses
Biocryst Pharmaceuticals Inc · SG&A Expenses
BCRX SG&A Expenses
Latest reported$337.33Mperiod ending
BCRX SG&A Expenses ($1.90M → $337.33M)
Annual SG&A Expenses
High-resolution chart · PNG
BCRX sg&a expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 348,647,000 | |
| 266,132,000 | |
| 213,894,000 | |
| 159,371,000 | |
| 118,818,000 | |
| 67,929,000 | |
| 37,121,000 | |
| 29,514,000 | |
| 13,933,000 | |
| 11,253,000 | |
| 13,047,000 | |
| 7,461,000 | |
| 5,220,000 | |
| 6,826,000 | |
| 12,332,000 | |
| 14,179,000 | |
| 11,481,000 | |
| 10,399,227 | |
| 9,465,962 | |
| 6,108,373 | |
| 3,686,323 | |
| 3,212,316 | |
| 2,812,000 | |
| 2,855,804 | |
| 3,052,089 | |
| 3,557,256 | |
| 2,900,000 | |
| 3,100,000 | |
| 2,700,000 | |
| 2,700,000 | |
| 2,200,000 | |
| 1,900,000 |